Valdemar Máximo

Citado por

	Total	Desde 2019
Citas	8147	2740
Índice h	42	25
Índice i10	74	56

660

330

165

495

2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202444 55 133 249 242 239 225 294 296 324 283 297 424 509 641 543 504 503 523 596 525 430 161

Acceso público

Ver todo

32 artículos

8 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Paula SoaresUniversity of Porto, Medical FacultyDirección de correo verificada de ipatimup.pt
Manuel Sobrinho-SimõesMedical Faculty of University of PortoDirección de correo verificada de ipatimup.pt
Joao VinagreInstitute of Pathology and Molecular Imunology of the University of PortoDirección de correo verificada de ipatimup.pt
Rui BatistaInstitute of Pathology and Molecular Imunology of the University of PortoDirección de correo verificada de ipatimup.pt
Vitor TroviscoResearch Associate, FlyBase/University of CambridgeDirección de correo verificada de cam.ac.uk
Raquel SerucaProfessora da Fac. de Medicina, IpatimupDirección de correo verificada de ipatimup.pt
Helena PopuloPostdoctoral fellowDirección de correo verificada de ipatimup.pt
Catarina EloyUniversity of Porto, Ipatimup/i3SDirección de correo verificada de ipatimup.pt
Marcelo Correia.Dirección de correo verificada de ipatimup.pt
Luisa PereiraResearcher, IPATIMUPDirección de correo verificada de ipatimup.pt
Rui Manuel ReisBarretos Cancer Hospital (Brazil) and Minho University (Portugal)Dirección de correo verificada de hcancerbarretos.com.br
Luis LimaProfessor, Instituto Politécnico do PortoDirección de correo verificada de estgf.ipp.pt
Fátima CarneiroProfessora de Medicina, Faculdade de MedicinaDirección de correo verificada de ipatimup.pt
Bogdanova TetianaState Institution "VP Komisarenko Institute of Endocrinology and Metabolism of NAMS of Ukraine"Dirección de correo verificada de bigmir.net
Ceu FigueiredoFaculty of Medicine; Ipatimup; i3S; University of PortoDirección de correo verificada de ipatimup.pt
Paula BoaventuraIPATIMUP - Institute of Molecular Pathology and Immunology of the University of PortoDirección de correo verificada de ipatimup.pt
David C. SamuelsAssociate Professor, Molecular Physiology and Biophysics, Vanderbilt University Medical CenterDirección de correo verificada de vanderbilt.edu
Jose Carlos Machadoi3s, IPATIMUP, Universidade do Porto, PortugalDirección de correo verificada de ipatimup.pt
Isabel Pereira-Castroi3S/IBMC - University of PortoDirección de correo verificada de ibmc.up.pt
silvia campelloUniversità di Roma Tor VergataDirección de correo verificada de uniroma2.it

Seguir

Valdemar Máximo

i3s, IPATIMUP, FMUP, Universidade do Porto, Portugal

Dirección de correo verificada de ipatimup.pt

Cancer Biology Cancer Metabolism Mitochondria Oncocytoma


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Frequency of TERT promoter mutations in human cancers J Vinagre, A Almeida, H Pópulo, R Batista, J Lyra, V Pinto, R Coelho, ... Nature communications 4 (1), 2185, 2013	980	2013
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC P Soares, V Trovisco, AS Rocha, J Lima, P Castro, A Preto, V Maximo, ... Oncogene 22 (29), 4578-4580, 2003	836	2003
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas M Melo, AG da Rocha, J Vinagre, R Batista, J Peixoto, C Tavares, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), E754-E765, 2014	588	2014
BRAF mutations are associated with some histological types of papillary thyroid carcinoma V Trovisco, I Vieira de Castro, P Soares, V Máximo, P Silva, J Magalhaes, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004	479	2004
Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors V Máximo, P Soares, J Lima, J Cameselle-Teijeiro, M Sobrinho-Simoes The American journal of pathology 160 (5), 1857-1865, 2002	339	2002
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness V Trovisco, P Soares, A Preto, IV de Castro, J Lima, P Castro, V Máximo, ... Virchows Archiv 446, 589-595, 2005	307	2005
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of … V Maximo, T Botelho, J Capela, P Soares, J Lima, A Taveira, T Amaro, ... British journal of cancer 92 (10), 1892-1898, 2005	258	2005
BRAF Mutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid Carcinomas J Lima, V Trovisco, P Soares, V Máximo, J Magalhães, G Salvatore, ... The Journal of Clinical Endocrinology & Metabolism 89 (9), 4267-4271, 2004	242	2004
Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration A Ferreira-da-Silva, C Valacca, E Rios, H Pópulo, P Soares, ... PloS one 10 (3), e0122308, 2015	210	2015
Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance V Máximo, M Sobrinho-Simões Virchows Archiv 437, 107-115, 2000	182	2000
Helicobacter pylori Infection Induces Genetic Instability of Nuclear and Mitochondrial DNA in Gastric Cells AMD Machado, C Figueiredo, E Touati, V Maximo, S Sousa, V Michel, ... Clinical Cancer Research 15 (9), 2995-3002, 2009	170	2009
STAT3 negatively regulates thyroid tumorigenesis JP Couto, L Daly, A Almeida, JA Knauf, JA Fagin, M Sobrinho-Simões, ... Proceedings of the National Academy of Sciences 109 (35), E2361-E2370, 2012	153	2012
Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma V Máximo, P Soares, R Seruca, AS Rocha, P Castro, M Sobrinho‐Simões Genes, Chromosomes and Cancer 32 (2), 136-143, 2001	151	2001
The diversity present in 5140 human mitochondrial genomes L Pereira, F Freitas, V Fernandes, JB Pereira, MD Costa, S Costa, ... The American Journal of Human Genetics 84 (5), 628-640, 2009	150	2009
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy N Pertega‐Gomes, S Felisbino, CE Massie, JR Vizcaino, R Coelho, ... The Journal of pathology 236 (4), 517-530, 2015	147	2015
Telomerase promoter mutations in cancer: an emerging molecular biomarker? J Vinagre, V Pinto, R Celestino, M Reis, H Pópulo, P Boaventura, M Melo, ... Virchows Archiv 465, 119-133, 2014	143	2014
Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas P Soares, J Lima, A Preto, P Castro, J Vinagre, R Celestino, J P Couto, ... Current genomics 12 (8), 609-617, 2011	120	2011
Intragenic mutations in thyroid cancer M Sobrinho-Simoes, V Maximo, AS Rocha, V Trovisco, P Castro, A Preto, ... Endocrinology and metabolism clinics of North America 37 (2), 333-362, 2008	120	2008
The biology and the genetics of Hrthle cell tumors of the thyroid V Mximo, J Lima, H Prazeres, P Soares, M Sobrinho-Simes Endocrine Related Cancer 19 (4), R131, 2012	116*	2012
Molecular pathology of well-differentiated thyroid carcinomas M Sobrinho-Simões, A Preto, AS Rocha, P Castro, V Máximo, E Fonseca, ... Virchows Archiv 447, 787-793, 2005	110	2005

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores